Earnings Call · Q1 FY2022·2022-05-12

Q1 22EPS +35.71%·Rev n/aQ4 21EPS -100.00%*·Rev n/aQ3 21EPS +40.00%·Rev n/aQ2 21EPS -55.56%·Rev n/a⚠ consensus missing

DYADIC INTERNATIONAL INC DYAI

Ping Rawson — Chief Financial Officer (CFO)

Mark Emalfarb — Chief Executive Officer (CEO)

Joe Hazelton — Pharmaceutical Development and Commercialization Executive

+5.8%1d on move date+3.4% vs SPY3d+12.0%5d+2.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DYAI calls or request research access.

More DYAI calls Browse calls Request research access